BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12109225)

  • 1. NM23 expression as prognostic factor in colorectal carcinoma.
    Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
    G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A; Katalinic A; Köckerling F; Wittekind C
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B; Somlai B; Tímár J
    Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic markers of the epithelial tumors of the large intestine].
    Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Covotta A; Soda G; Bosco D; Nardoni S; Bezzi M; Beltrami V
    Ann Ital Chir; 2002; 73(6):587-96; discussion 597. PubMed ID: 12820582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of prognostic significance of nm23 expression in human primary breast cancer.
    Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T
    Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
    Al-Maghrabi JA; Asa SL
    Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H; Mao H; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nm23-H1 gene expression in ovarian tumors--a potential tumor marker.
    Kapitanovic S; Spaventi R; Vujsic S; Petrovic Z; Kurjak A; Pavelic ZP; Gluckman JL; Stambrook PJ; Pavelic K
    Anticancer Res; 1995; 15(2):587-90. PubMed ID: 7763042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nm23 and cathepsin D expression in laryngeal carcinomas.
    Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
    Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of nm23 protein in progression of sporadic adenocarcinoma of the large intestine].
    Paluszkiewicz P; Pawłowska-Wakowicz B; Karski J
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():82-6. PubMed ID: 9446409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
    Royds JA; Cross SS; Silcocks PB; Scholefield JH; Rees RC; Stephenson TJ
    J Pathol; 1994 Mar; 172(3):261-6. PubMed ID: 8195929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.